Cite

HARVARD Citation

    Anastasilakis, A. et al. (2017). Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment. European journal of endocrinology. 176 (6), pp. 677-683. [Online]. 
  
Back to record